A phase III trial of CHOP vs CHOP + rituximab vs CHOP + 1-131 tositumomab for newly diagnosed follicular non-Hodgkin lymphoma.

Journal: Clinical advances in hematology & oncology : H&O 2007;4(7):536-8

PMID: 17147240

Abstract

Link outs

Free resources

Research Materials:

https://antibodies.cancer.gov/detail/CPTC-DDIT3-1

MeSH Terms: Antibodies, Monoclonal, Antibodies, Monoclonal, Murine-Derived, Antineoplastic Combined Chemotherapy Protocols, Combined Modality Therapy, Cyclophosphamide, Doxorubicin, Humans, Iodine Radioisotopes, Lymphoma, Follicular, Prednisone, Rituximab, Vincristine

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.